OSEBX1 912,70−0,37 %
EQNR338,10−0,27 %
DNB280,75−0,90 %
MOWI194,55−1,44 %
Brent$100,56+0,50 %
Gold$4 746,20+0,75 %
USD/NOK9,2006−1,21 %
EUR/NOK10,8323−0,79 %
SPX7 388,63+0,70 %
NDX28 999,18+1,52 %
LIVE · 14:06 UTC
DSYJ.J60

Discovery Ltd

Life & Health InsuranceVerified
Score breakdown
Profitability+35Sentiment+30Risk penalty-3Missing signals-3
Quality breakdown
Key fields100Profile38Conclusion100AI synthesis40Observations23

Discovery Ltd maintains a capital structure with a debt-to-equity ratio of 0.66, indicating a moderate reliance on debt financing [doc:HA-latest]. The company's liquidity position is characterized as medium, with cash and equivalents amounting to ZAR 6.696 billion, but net cash is negative after subtracting total debt [doc:HA-latest]. Free cash flow stands at ZAR 8.027 billion, suggesting the company generates sufficient cash to support operations and potentially fund growth initiatives [doc:HA-latest]. In terms of profitability, Discovery Ltd reports a return on equity (ROE) of 14.56%, which is a strong indicator of efficient use of shareholders' equity to generate profits [doc:HA-latest]. The return on assets (ROA) is 2.92%, which is in line with industry expectations for a diversified financial services firm [doc:HA-latest]. These metrics suggest that the company is effectively leveraging its asset base to generate returns, although the ROA is relatively modest compared to the ROE. The company's revenue is concentrated across three primary geographic segments: South Africa, the United Kingdom, and Vitality Global. South Africa is the largest market, with Discovery Health, Discovery Life, Discovery Invest, Discovery Insure, and Discovery Bank as key offerings [doc:HA-latest]. The United Kingdom segment includes VitalityHealth, VitalityLife, and VitalityCar, while Vitality Global encompasses international operations and the Vitality Network [doc:HA-latest]. This geographic diversification helps mitigate regional economic risks but also exposes the company to varying regulatory environments and market conditions. Looking at the growth trajectory, Discovery Ltd is expected to maintain a stable performance in the current fiscal year, with analysts providing a mean price target of ZAR 286.46 and a median of ZAR 295.00 [doc:HA-latest]. The company's operating income of ZAR 14.564 billion and net income of ZAR 9.564 billion indicate a solid financial foundation for future growth [doc:HA-latest]. The capital expenditure of ZAR -1.976 billion suggests that the company is not heavily investing in new projects, which may indicate a focus on maintaining current operations rather than aggressive expansion. The risk assessment for Discovery Ltd highlights a medium liquidity risk and a low dilution risk [doc:HA-latest]. The company's liquidity position is supported by its free cash flow, but the negative net cash position after subtracting total debt indicates potential liquidity constraints [doc:HA-latest]. The dilution risk is low, with no significant changes in shares outstanding between basic and diluted figures [doc:HA-latest]. The company's risk profile is further influenced by its exposure to the financial services sector, which is subject to regulatory changes and economic fluctuations. Recent events and filings indicate that Discovery Ltd continues to operate within a stable regulatory environment, with no major disruptions reported in the latest financial snapshot [doc:HA-latest]. The company's focus on a shared-value insurance model and its diversified business segments contribute to its resilience in the face of market volatility [doc:HA-latest].

Profile
CompanyDiscovery Ltd
TickerDSYJ.J
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. Discovery Ltd is an integrated financial services organization that operates in healthcare, life insurance, short-term insurance, long-term savings, banking, and wellness markets, primarily through a shared-value insurance model across its South Africa, United Kingdom, and Vitality Global business strands [doc:HA-latest].

Classification. Discovery Ltd is classified under the Life & Health Insurance industry within the Financials sector, with a confidence level of 0.92 based on verified market data [doc:HA-latest].

Discovery Ltd maintains a capital structure with a debt-to-equity ratio of 0.66, indicating a moderate reliance on debt financing [doc:HA-latest]. The company's liquidity position is characterized as medium, with cash and equivalents amounting to ZAR 6.696 billion, but net cash is negative after subtracting total debt [doc:HA-latest]. Free cash flow stands at ZAR 8.027 billion, suggesting the company generates sufficient cash to support operations and potentially fund growth initiatives [doc:HA-latest]. In terms of profitability, Discovery Ltd reports a return on equity (ROE) of 14.56%, which is a strong indicator of efficient use of shareholders' equity to generate profits [doc:HA-latest]. The return on assets (ROA) is 2.92%, which is in line with industry expectations for a diversified financial services firm [doc:HA-latest]. These metrics suggest that the company is effectively leveraging its asset base to generate returns, although the ROA is relatively modest compared to the ROE. The company's revenue is concentrated across three primary geographic segments: South Africa, the United Kingdom, and Vitality Global. South Africa is the largest market, with Discovery Health, Discovery Life, Discovery Invest, Discovery Insure, and Discovery Bank as key offerings [doc:HA-latest]. The United Kingdom segment includes VitalityHealth, VitalityLife, and VitalityCar, while Vitality Global encompasses international operations and the Vitality Network [doc:HA-latest]. This geographic diversification helps mitigate regional economic risks but also exposes the company to varying regulatory environments and market conditions. Looking at the growth trajectory, Discovery Ltd is expected to maintain a stable performance in the current fiscal year, with analysts providing a mean price target of ZAR 286.46 and a median of ZAR 295.00 [doc:HA-latest]. The company's operating income of ZAR 14.564 billion and net income of ZAR 9.564 billion indicate a solid financial foundation for future growth [doc:HA-latest]. The capital expenditure of ZAR -1.976 billion suggests that the company is not heavily investing in new projects, which may indicate a focus on maintaining current operations rather than aggressive expansion. The risk assessment for Discovery Ltd highlights a medium liquidity risk and a low dilution risk [doc:HA-latest]. The company's liquidity position is supported by its free cash flow, but the negative net cash position after subtracting total debt indicates potential liquidity constraints [doc:HA-latest]. The dilution risk is low, with no significant changes in shares outstanding between basic and diluted figures [doc:HA-latest]. The company's risk profile is further influenced by its exposure to the financial services sector, which is subject to regulatory changes and economic fluctuations. Recent events and filings indicate that Discovery Ltd continues to operate within a stable regulatory environment, with no major disruptions reported in the latest financial snapshot [doc:HA-latest]. The company's focus on a shared-value insurance model and its diversified business segments contribute to its resilience in the face of market volatility [doc:HA-latest].
Key takeaways
  • Discovery Ltd maintains a strong return on equity (14.56%) but a modest return on assets (2.92%), indicating efficient use of equity but less efficient use of total assets.
  • The company's liquidity position is medium, with a free cash flow of ZAR 8.027 billion but a negative net cash position after subtracting total debt.
  • Discovery Ltd's business is geographically diversified across South Africa, the United Kingdom, and Vitality Global, which helps mitigate regional economic risks.
  • Analysts provide a mean price target of ZAR 286.46 and a median of ZAR 295.00, suggesting a stable outlook for the company.
  • The company's risk profile is characterized by medium liquidity risk and low dilution risk, with no significant changes in shares outstanding.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyZAR
Revenue
Gross profit
Operating income$14.56B
Net income$9.56B
R&D
SG&A
D&A
SBC
Operating cash flow$8.67B
CapEx-$1.98B
Free cash flow$8.03B
Total assets$327.45B
Total liabilities$261.75B
Total equity$65.70B
Cash & equivalents$6.70B
Long-term debt$43.37B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$14.56B$9.56B$8.03B
FY-1$11.41B$7.56B$6.16B
FY-2$10.30B$6.58B$6.16B
FY-3$8.03B$5.48B$5.49B
FY-4$5.71B$3.22B$3.15B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$327.45B$65.70B$6.70B
FY-1$279.63B$54.45B$5.36B
FY-2$258.74B$49.72B$4.51B
FY-3$271.37B$53.55B
FY-4$246.82B$46.41B$20.01B
PeriodOCFCapExFCFSBC
FY0$8.67B-$1.98B$8.03B
FY-1$2.73B-$2.20B$6.16B
FY-2$2.55B-$2.31B$6.16B
FY-3$3.60B-$1.84B$5.49B
FY-4$10.41B-$1.86B$3.15B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$65.70B
Net cash-$36.68B
Current ratio
Debt/Equity0.7
ROA2.9%
ROE14.6%
Cash conversion91.0%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Life & Health Insurance · cohort 1 companies
MetricDSYJ.JActivity
Op margin21.1% medp25 16.7% · p75 136.5%
Net margin10.4% medp25 5.7% · p75 19.8%
Gross margin21.0% medp25 21.0% · p75 21.0%
CapEx / revenue2.4% medp25 2.4% · p75 2.4%
Debt / equity66.0%48.5% medp25 43.7% · p75 53.3%top quartile
Observations
IR observations
Mean price target286.46 ZAR
Median price target295.00 ZAR
High price target309.00 ZAR
Low price target240.00 ZAR
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count2.00
Buy count4.00
Hold count2.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate17.39 ZAR
Last actual EPS14.39 ZAR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-01 10:53 UTC#02c3f4d0
Source: analysis-pipeline (hybrid)Generated: 2026-05-01 10:55 UTCJob: 440002d1